Christophe Thurieau
Chief Executive Officer at Symphogen A/S
Christophe Thurieau active positions
| Companies | Position | Start | End |
|---|---|---|---|
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Director/Board Member | 2020-06-03 | - |
| Chief Executive Officer | 2020-06-03 | - |
Career history of Christophe Thurieau
Former positions of Christophe Thurieau
| Companies | Position | Start | End |
|---|---|---|---|
| IPSEN | Corporate Officer/Principal | - | - |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Director/Board Member | 2010-04-26 | - |
| Corporate Officer/Principal | - | 2010-04-26 |
Training of Christophe Thurieau
| Harvard University | Undergraduate Degree |
Statistics
International
| France | 3 |
| Switzerland | 2 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IPSEN | Health Technology |
| Private companies | 3 |
|---|---|
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Christophe Thurieau
- Experience
